Osteoporosis News and Research

Latest Osteoporosis News and Research

FDA grants Breakthrough Therapy designation to GSK's Promacta/Revolade for treatment of cytopenias

Ligand Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration has granted its partner GlaxoSmithKline plc Breakthrough Therapy designation for Promacta/Revolade (eltrombopag) for the treatment of cytopenias in patients with severe aplastic anemia (SAA) who have had insufficient response to immunosuppressive therapy.

3 Feb 2014

More than 1/2 of relevant websites carry 'unacceptable' information about vertebroplasty

Most websites with information on vertebroplasty - a procedure in which a special medical-grade cement mixture is injected into a fractured vertebra - do not paint the full picture about the pros, cons and alternatives of the treatment.

31 Jan 2014

Finding could lead to new treatments for osteoporosis

Scientists at Washington University School of Medicine in St. Louis have discovered what appears to be a potent stimulator of new bone growth. The finding could lead to new treatments for osteoporosis and other diseases that occur when the body doesn't make enough bone.

31 Jan 2014

Scientists develop automated system that identifies high-risk osteoporosis patients

An automated system that identifies high-risk osteoporosis patients being treated for fractures and can generate letters encouraging follow-up is an effective way to promote osteoporosis intervention and prevent future fractures, according to Penn State College of Medicine researchers.

29 Jan 2014

ULCA study shows men who married below 25 years of age had lower bone strength

Marriage is good for the health of men's bones - but only if they marry when they're 25 or older, new UCLA researcher suggests.

23 Jan 2014

Strontium should no longer be used for osteoporosis treatment, warns European Agency

All persons taking strontium supplements are warned that significant risks have been identified. Strontium drugs are not approved for treatment of osteoporosis in the United States. Now, the Risk Assessment Committee of the European Medicines Agency recommended that strontium should no longer be used to treat osteoporosis in Europe. The drugs Protelos/Osseor were specifically named as brand names for strontium ranelate.

19 Jan 2014

Study explores the role of DNA in predisposing individuals to diseases

A group of international researchers, led by a research fellow in the Harvard Medical School-affiliated Institute for Aging Research at Hebrew SeniorLife, published a paper today in Cell describing a study aimed at better understanding how inherited genetic differences, or variants, predispose certain individuals to develop diseases such as type 2 diabetes.

16 Jan 2014

FDA accepts NPS Pharmaceuticals' Natpara BLA for review

NPS Pharmaceuticals, Inc., a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that the U.S. Food and Drug Administration has accepted and filed for review the company's Biologics License Application for Natpara (recombinant human parathyroid hormone 1-84, (rhPTH[1-84])) for the treatment of hypoparathyroidism.

7 Jan 2014

Amneal launches generic Esomeprazole strontium delayed-release capsules 49.3 mg

Amneal Pharmaceuticals LLC today announced the launch of generic Esomeprazole strontium delayed-release capsules 49.3 mg. This new esomeprazole therapy is the generic equivalent of the recently launched brand Esomeprazole strontium. It contains the same active moiety (esomeprazole) in a different salt form as found in the leading PPI brand Nexium (esomeprazole magnesium) and presents a potentially more affordable treatment option for GERD in adult patients.

6 Jan 2014

Amgen announces romosozumab Phase 2 trial results in postmenopausal women with low BMD

Amgen and UCB (Euronext Brussels:UCB) today announced results from a Phase 2 trial evaluating romosozumab (AMG 785/CDP7851) in postmenopausal women with low bone mineral density (BMD).

2 Jan 2014

AACE releases first 2013 list of most frequently searched endocrine medical conditions

The American Association of Clinical Endocrinologists (AACE) today released its first annual list of the most frequently searched endocrine medical conditions for 2013, as measured by visits to the organization's patient education website, www.empoweryourhealth.org.

28 Dec 2013

Protein responsible for excretion of copper in body cells utilizes unique transport mechanism

We are fundamentally dependent on the presence of copper in the cells of the body. Copper is actually part of the body's energy conversion and protective mechanisms against oxygen radicals, as well as part of the immune system, and it also has great importance for the formation of e.g. hormones and neurotransmitters.

28 Dec 2013

Osteoarthritis patients can carry out progressive exercise to maintain bone health

The postmenopausal women who may be at risk of osteoporosis (bone loss), as well as at risk of osteoarthritis, can safely carry out progressive high-impact training to maintain bone health and physical function.

19 Dec 2013

BioLineRx enrolls first patient in BL-7010 Phase 1/2 trial for treatment of celiac disease

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today enrollment of the first patient in a Phase 1/2 trial of BL-7010, for the treatment of celiac disease. The first patient was enrolled at Tampere Hospital in Finland, a world-leading site for celiac disease research. Results are expected in mid-2014.

18 Dec 2013

Amneal's Esomeprazole Strontium 49.3 mg delayed-release capsules now available for GERD patients

Amneal Pharmaceuticals LLC today announced the launch of its branded Esomeprazole Strontium 49.3 mg delayed-release capsules. Esomeprazole Strontium contains the same active moiety (esomeprazole) in a different salt form as found in the branded proton-pump inhibitor Nexium (esomeprazole magnesium) and is a new option for adult patients for the short term treatment of gastroesophageal reflux disease.

17 Dec 2013

IOF Young Investigator Awards presented to five researchers at 4th Asia-Pacific Osteoporosis Meeting

Today, the International Osteoporosis Foundation recognized the outstanding work of five young researchers from China, Chinese Taipei, Hong Kong, Malaysia and Pakistan.

16 Dec 2013

Exercise in middle age protects against sarcopenia and maintains muscle strength, physical performance

A cross-sectional study by investigators from Tokyo University has found that exercising in middle age is a protective factor against sarcopenia and effective in maintaining muscle strength and physical performance.

16 Dec 2013

$Early initiation of treatment after primary hip fracture helps reduce second fracture incidence, mortality$

Early initiation of treatment after primary hip fracture helps reduce second fracture incidence, mortality

Research presented today at the 4th Asia-Pacific Osteoporosis Meeting showed that second hip fractures are more deadly than first hip fractures. Based in Hong Kong, the study evaluated the overall incidence of a second hip fracture and subsequent mortality in 43,832 patients, aged 65 or above, with operatively treated first hip fracture during the years 2000-2011.

15 Dec 2013

Geriatrician draws specific conclusions about Santa’s health habits

Children around the world look to Santa Claus as a model of good behavior. But can this sleigh-riding bearer of goodies also be a model good health habits for adults?

13 Dec 2013

$Patients with Colles' fracture are at increased risk of subsequent hip fractures: Study$

Patients with Colles' fracture are at increased risk of subsequent hip fractures: Study

A new study presented today at the IOF Regionals 4th Asia-Pacific Osteoporosis Meeting in Hong Kong supports widespread evidence that individuals who have suffered a fracture are at significantly increased risk of subsequent hip fractures. In fact, previous studies have shown that half of patients presenting with hip fractures have suffered a prior fracture.

13 Dec 2013

Osteoporosis News and Research

Latest Osteoporosis News and Research

FDA grants Breakthrough Therapy designation to GSK's Promacta/Revolade for treatment of cytopenias

More than 1/2 of relevant websites carry 'unacceptable' information about vertebroplasty

Finding could lead to new treatments for osteoporosis

Scientists develop automated system that identifies high-risk osteoporosis patients

ULCA study shows men who married below 25 years of age had lower bone strength

Strontium should no longer be used for osteoporosis treatment, warns European Agency

Study explores the role of DNA in predisposing individuals to diseases

FDA accepts NPS Pharmaceuticals' Natpara BLA for review

Amneal launches generic Esomeprazole strontium delayed-release capsules 49.3 mg

Amgen announces romosozumab Phase 2 trial results in postmenopausal women with low BMD

AACE releases first 2013 list of most frequently searched endocrine medical conditions

Protein responsible for excretion of copper in body cells utilizes unique transport mechanism

Osteoarthritis patients can carry out progressive exercise to maintain bone health

BioLineRx enrolls first patient in BL-7010 Phase 1/2 trial for treatment of celiac disease

Amneal's Esomeprazole Strontium 49.3 mg delayed-release capsules now available for GERD patients

IOF Young Investigator Awards presented to five researchers at 4th Asia-Pacific Osteoporosis Meeting

Exercise in middle age protects against sarcopenia and maintains muscle strength, physical performance

Early initiation of treatment after primary hip fracture helps reduce second fracture incidence, mortality

Geriatrician draws specific conclusions about Santa’s health habits

Patients with Colles' fracture are at increased risk of subsequent hip fractures: Study

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Osteoporosis News and Research

Latest Osteoporosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in